These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20471543)

  • 1. Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated.
    Navigante AH; Castro MA; Cerchietti LC
    J Pain Symptom Manage; 2010 May; 39(5):820-30. PubMed ID: 20471543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
    Navigante AH; Cerchietti LC; Castro MA; Lutteral MA; Cabalar ME
    J Pain Symptom Manage; 2006 Jan; 31(1):38-47. PubMed ID: 16442481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential opioid-sparing effect of regular benzodiazepines in dyspnea: longer duration of studies needed.
    Currow DC; Abernethy AP
    J Pain Symptom Manage; 2010 Nov; 40(5):e1-2; author reply e2-4. PubMed ID: 20813495
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?
    Hu WY; Chiu TY; Cheng SY; Chen CY
    J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
    Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
    J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Palliative" and not "terminal" sedation.
    Koh YH; Lee OK; Wu HY
    J Pain Symptom Manage; 2009 Apr; 37(4):e6-8. PubMed ID: 19345295
    [No Abstract]   [Full Text] [Related]  

  • 7. Midazolam as adjunct therapy to morphine to relieve dyspnea?
    Sironi O; Sbanotto A; Banfi MG; Beltrami C
    J Pain Symptom Manage; 2007 Mar; 33(3):233-4; author reply 234-6. PubMed ID: 17349490
    [No Abstract]   [Full Text] [Related]  

  • 8. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
    Clemens KE; Klaschik E
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):529-32. PubMed ID: 16612168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does nebulized morphine offer symptom relief to patients with disabling dyspnea during end-stage disease?
    Eaton B; Hall J; MacDonald S
    Can Fam Physician; 1999 Feb; 45():319-20. PubMed ID: 10065305
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dyspnea in cancer: causes and symptomatic treatment].
    Sleijfer DT; van der Werf TS; de Mulder PH
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2421-4. PubMed ID: 10608976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we really say that nebulized morphine works?
    Lasheen W; Panneerselvam A; Davis MP
    J Pain Symptom Manage; 2006 Aug; 32(2):101-2; author reply 102-3. PubMed ID: 16877173
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid-induced neurotoxicity.
    Gallagher R
    Can Fam Physician; 2007 Mar; 53(3):426-7. PubMed ID: 17872676
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of ondansetron in lower extremity bone surgery on morphine and tramadol consumption using patient controlled analgesia].
    Cubukçu Z; Ozbek H; Güneş Y; Gündüz M; Ozcengiz D; Işik G
    Agri; 2007 Jan; 19(1):36-41. PubMed ID: 17457705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy.
    Alhashemi JA; Kaki AM
    Can J Anaesth; 2004 Apr; 51(4):342-7. PubMed ID: 15064262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulized morphine for relief of dyspnea due to chronic lung disease.
    Brown SJ; Eichner SF; Jones JR
    Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.
    Clemens KE; Klaschik E
    J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain.
    Mercadante S; Salvaggio L; Dardanoni G; Agnello A; Garofalo S
    J Pain Symptom Manage; 1998 Feb; 15(2):76-81. PubMed ID: 9494305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.